zeranol has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coe, JE; Ishak, KG; Ross, MJ | 1 |
| Ishiwata, I; Koyama, T; Murata, H; Withanage, GS | 1 |
2 other study(ies) available for zeranol and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Estrogen-induced hepatic toxicity and hepatic cancer: differences between two closely related hamster species.
Topics: Adenoma, Liver Cell; Animals; Bilirubin; Carcinoma, Hepatocellular; Cricetinae; Cricetulus; Diethylstilbestrol; Estrogens; Female; Inclusion Bodies; Liver; Liver Neoplasms, Experimental; Male; Medroxyprogesterone Acetate; Mifepristone; Species Specificity; Tamoxifen; Zeranol | 1998 |
Agonistic and antagonistic effects of zearalenone, an etrogenic mycotoxin, on SKN, HHUA, and HepG2 human cancer cell lines.
Topics: Adenocarcinoma; Carcinoma, Hepatocellular; Cell Division; Colorimetry; Dose-Response Relationship, Drug; Endometrial Neoplasms; Estradiol; Estrogens, Non-Steroidal; Female; Humans; Leiomyosarcoma; Tumor Cells, Cultured; Zearalenone; Zeranol | 2001 |